Ledipasvir/sofosbuvir

لدیپاسویر/سوفوسبوویر

⚠ Unverified

🦠 Antiinfectives For Systemic UseHCV direct-acting antiviral

Market / country: 🇺🇸 USA

Harvoni (US)

🧮 Dose calculator

Chronic hepatitis C · Regimen source: FDA Harvoni · 2.3FDA Harvoni · 2.4, Table 2

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ When given with ribavirin, ribavirin contraindications also apply. FDA Harvoni · 4

Warnings

  • • Boxed warning: HBV reactivation in HCV/HBV co-infection (sometimes fulminant hepatitis and death) — test HBsAg and anti-HBc first. FDA Harvoni · Boxed Warning
  • • Serious symptomatic bradycardia with amiodarone (not recommended together); reduced effect with P-gp inducers (rifampin, St John’s wort). FDA Harvoni · 5

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label: no adequate human data; no adverse developmental outcomes in animals. With ribavirin the combination is contraindicated in pregnancy. FDA Harvoni · 8.1

    “No adequate human data are available to establish whether or not HARVONI poses a risk to pregnancy outcomes. In animal reproduction studies, no evidence of adverse developmental outcomes was observed with the components of HARVONI.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Harvoni · 8.2

    “When administered to lactating rats, ledipasvir was detected in the plasma of nursing pups likely due to the presence of ledipasvir in milk, without clear effects on nursing pups [see Data ].”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Harvoni · 8.4

    “The safety, pharmacokinetics, and efficacy of HARVONI for treatment of HCV genotype 1 and 4 infection in treatment-naïve and treatment-experienced pediatric patients 3 years of age and older without cirrhosis or with compensated cirrhosis have been established in an open-label, multicenter clinical trial (Study 1116, …”
  • 👴 Older adultsNo specific problem stated

    Label: no specific difference or dose adjustment stated for older adults. FDA Harvoni · 8.5

    “No dosage adjustment of HARVONI is warranted in geriatric patients [see Clinical Pharmacology (12.3) ] .”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Harvoni · 8.3

    “If HARVONI is administered with ribavirin, the information for ribavirin with regard to pregnancy testing, contraception, and infertility also applies to this combination regimen.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav